These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 355566)

  • 21. Humoral and cell mediated immune responses against Schistosoma spindale in BALB/c mice.
    Prechatangkit B; Dhaliwal JS; Ambu S
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):170-5. PubMed ID: 7825008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The self-cure phenomenon in definitive hosts infected with schistosomes].
    Wang WQ; Liu SX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(3):179-82. PubMed ID: 14628355
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunity to schistosomes: the target.
    Smithers SR; McLaren DJ; Ramalho-Pinto FJ
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 2):11-9. PubMed ID: 339756
    [No Abstract]   [Full Text] [Related]  

  • 24. Macrophages as effector cells of protective immunity in murine schistosomiasis. IV. Coincident induction of macrophage activation for extracellular killing of schistosomula and tumor cells.
    James SL; Leonard EJ; Meltzer MS
    Cell Immunol; 1982 Nov; 74(1):86-96. PubMed ID: 7159937
    [No Abstract]   [Full Text] [Related]  

  • 25. Serodiagnosis of Schistosoma mansoni in man by immunoelectroadsorption.
    Mathot C; Rothen A
    Am J Trop Med Hyg; 1968 Sep; 17(5):756-9. PubMed ID: 5676659
    [No Abstract]   [Full Text] [Related]  

  • 26. Eosinophil-mediated destruction of Schistosoma mansoni eggs III. lymphokine involvement in the induction of eosinophil functional abilities.
    James SL; Colley DG
    Cell Immunol; 1978 Jun; 38(1):48-58. PubMed ID: 566624
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral and cellular immune response in schistosomiasis pre and post praziquantel therapy.
    Hamadto HH; Rashed SM; el Said A; Elhayawan IA
    J Egypt Soc Parasitol; 1990 Dec; 20(2):667-72. PubMed ID: 2230324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity ot Schistosoma mansoni: antibody-dependent eosinophil-mediated damage to schistosomula.
    David JR; Butterworth AE
    Fed Proc; 1977 Jul; 36(8):2176-80. PubMed ID: 872950
    [No Abstract]   [Full Text] [Related]  

  • 29. Kinetics and characterization of antigen-binding and antibody-producing cells in the regional draining lymph nodes and spleen during initial murine schistosomiasis. I. Cellular responses against cercarial immunogens.
    Khoury PB; Lloyd SS; Reid WA; Weiner DJ; Phillips SM; Soulsby EJ
    Cell Immunol; 1981 Apr; 59(2):233-45. PubMed ID: 6974599
    [No Abstract]   [Full Text] [Related]  

  • 30. The mouse model of schistosome immunity.
    Smithers SR; Simpson AJ; Yi X; Omer-Ali P; Kelly C; McLaren DJ
    Acta Trop Suppl; 1987 Jun; 12():21-30. PubMed ID: 2442986
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypersensitivity, tolerance and immunopathology in schistosomiasis: some current concepts and speculations.
    Lewert RM
    Southeast Asian J Trop Med Public Health; 1976 Jun; 7(2):289-300. PubMed ID: 828975
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunity to schistosomes: progress toward vaccine.
    Capron A; Dessaint JP; Capron M; Ouma JH; Butterworth AE
    Science; 1987 Nov; 238(4830):1065-72. PubMed ID: 3317823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic markers in schistosomiasis.
    Deelder AM
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():125-7. PubMed ID: 1342708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immunity to schistosomes. Evaluation of mechanisms operating against lung-stage parasites which might be exploited in a vaccine.
    Pemberton RM; Malaquias LC; Falcao PL; Silveira AM; Rabello AL; Katz N; Amorim M; Mountford AP; Coffman RL; Correa-Oliveira R
    Trop Geogr Med; 1994; 46(4 Spec No):247-54. PubMed ID: 7825229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relevance of schistosomiasis.
    Warren KS
    N Engl J Med; 1980 Jul; 303(4):203-6. PubMed ID: 6991944
    [No Abstract]   [Full Text] [Related]  

  • 36. [Synthesis of immunity phenomena and immunopathology in bilharziasis. Consequences for man in endemic areas].
    Nozais JP
    Med Trop (Mars); 1982; 42(6):637-40. PubMed ID: 7154911
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on heterologous immunity in schistosomiasis. 5. Heterologous schistosome immunity in sheep.
    Preston JM; Nelson GS; Saeed AA
    Bull World Health Organ; 1972; 47(5):587-90. PubMed ID: 4540678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunity in schistosomiasis].
    Shuĭkina EE; Osipova SO
    Med Parazitol (Mosk); 1993; (4):54-8. PubMed ID: 7968815
    [No Abstract]   [Full Text] [Related]  

  • 39. Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view.
    Capron A; Dessaint JP
    Annu Rev Immunol; 1985; 3():455-76. PubMed ID: 2933049
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-specific cell mediated immunity in patients infected with Schistosoma mansoni in Kenya.
    Cottrell BJ; Humber D; Sturrock RF; Seitz H; Rees P
    Trans R Soc Trop Med Hyg; 1982; 76(2):234-7. PubMed ID: 6980505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.